Navigation Links
New Advances and Opportunities in Managing Pain: Translational Animal Models, New Webinar Hosted by Xtalks
Date:6/12/2013

Toronto, Canada (PRWEB) June 12, 2013

Animal models provide pivotal systems for the preclinical study of pain. Recently, there has been increased attention and discussion focused on the lack of translation of potential pain therapeutics from preclinical models to clinical settings. Measures of pain within these models have typically relied on evoked withdrawal responses to noxious stimuli (hyperalgesia) or normally non-noxious stimuli (allodynia). There have been new efforts in enhancing translation of preclinical findings to the clinical chronic pain condition. Additionally, novel measures of pain behaviors are being developed within animal pain models to better address the multidimensional aspect of pain.

This webinar reviews the challenges and current opportunities in pain research focusing on chronic pain. Chronic pain patients, especially those with neuropathic pain and cancer pain, are often not adequately treated by analgesics now on the market. Additionally, the adverse side effect profiles of the most commonly used medications, such as opiates, can further diminish quality of life in these patients. These issues emphasize the need for development of new, mechanism based therapeutics.

This event features experts with experience working with preclinical models of chronic pain including nerve injury, chemotherapy, bone cancer, and osteoarthritis. An overview of recent advances in preclinical measures of pain will be presented, including new assays of spontaneous or ongoing pain that is not evoked by stimuli applied by the experimenter.

Join us for a comprehensive presentation and interactive Q&A session!

To learn more about the event, visit: http://xtalks.com/Translational-Animal-Models-of-Pain.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of education
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. EGEN, Inc. Advances a Systemically Delivered RNAi Therapeutic for the Treatment of Pulmonary Arterial Hypertension (PAH)
2. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
3. R. Graham Cooks Wins Dreyfus Prize in the Chemical Sciences; Purdue Chemist Honored for Advances in Chemical Instrumentation
4. PathoGenetix Advances Commercialization of New RESOLUTION Microbial Genotyping System for Rapid Bacterial Serotyping and Strain Typing
5. Latest Advances in Treatment for Alzheimers, Traumatic Brain Injury and Stroke to Be Presented at Symposium
6. arGEN-X advances ARGX-113 into preclinical development for autoimmune disorders
7. Cancer Advances Announces Issuance of Three New Patents to Its Suite of Gastrin Inhibitor Products
8. SPIE Counts Advances in Sustainable Photonics on List of Solutions to Celebrate on Earth Day
9. Advances in Molecular Testing Offer New Hope for Lung Cancer Patients
10. Douglas Harrington, MD Addresses Select Group Of Physicians Regarding Latest Advances In Cardiovascular Risk Assessment
11. In Focus with Martin Sheen Exploring the Advances of Molecular Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... for its newly developed Bruton,s tyrosine kinase (BTK) ... completed. The results of these preclinical evaluations have ... Administration. The feedback received from the Agency is ... study. Additional preclinical work is required to begin ...
(Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:2/27/2015)... 27, 2015 The fully automated ... UC) can sequentially analyze up to 48 samples ... high-sensitivity detection of targets by mass spectrometry. ... fulfill the measurement requirements of a wide range ... drug delivery and search for disease biomarkers, additives ...
(Date:2/27/2015)... DIEGO , Feb. 27, 2015  Pfenex Inc. ... the development of biosimilar therapeutics, today announced that it ... Francisco Marriott Marquis on March 2 nd at ... participate on a panel discussing the current state of ... of Biosimilars . For more information ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Global Market Report of Trypsin 2014-2018 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3
... MYL ) today announced that its subsidiary ... USP, 4.8355 mg/325 mg, based on an agreement with ... version of Endo Pharmaceuticals, Percodan® Tablets, a treatment for ... Aspirin Tablets had U.S. sales of approximately $6.5 million ...
... NEW YORK, May 5, 2011 Reportlinker.com announces ... in its catalogue: Tumor Markers ... Forecasts to 2017 http://www.reportlinker.com/p0490349/Tumor-Markers---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html ... Analysis, Competitive Landscape and Market Forecasts to 2017 ...
... Inc. (OTCBB: GOVX), a biotechnology company that creates, ... its 2010 Annual Report and President,s Letter to ... information on the state of the Company,s finances ... GeoVax,s President Robert T. McNally, Ph.D., provides a ...
Cached Biology Technology:Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 14GeoVax Labs Announces Availability of 2010 Annual Report and President's Letter to Stockholders 2
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... Conn. , Jan. 26, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... new corporate website ( http://www.nxt-id.com/ ) as part of ... smart wallet. The Company launched its new consumer website ... Gino Pereira , CEO of NXT-ID said, "Our new ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... antibiotics that followed it, streptococcus bacteria have remained a ... the superb evolutionary skills of this pathogen to rapidly ... this week in Science , scientists from Rockefeller ... sequencing to identify the precise steps in the molecular ...
... is available in German . , Plants are ... against these herbivores they developed complex defense mechanisms over the ... of toxic chemical substances. For decades it has been controversially ... the plants. Now, using a new method the ecologists and ...
... The European Commission has given the green light to ... Nutrition Research for Africa in the Years to come,. The ... and five European institutions coordinated by the Institute of Tropical ... million Euros will be invested to rethink the research agenda ...
Cached Biology News:New research traces evolutionary path of multidrug-resistant strep bacteria 2New research traces evolutionary path of multidrug-resistant strep bacteria 3Initiative to tackle malnutrition in Africa 2
Bovine Coronary Artery Endothelial Cells (BCAEC) (>500,000 cells)...
Bovine Renal Artery Endothelial Cells (BRAEC) (>500,000 cells)...
Bovine Aortic Smooth Muscle Cells (BAOSMC) (>500,000 cells)...
Black Polypropylene 384 Round Well Plate 70/Box...
Biology Products: